Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERDAFITINIB vs ERYTHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERDAFITINIB vs ERYTHROMYCIN: Safety Overview

Metric ERDAFITINIB ERYTHROMYCIN
Total FAERS Reports 1,106 7,325
Deaths Reported 315 467
Death Rate 28.5% 6.4%
Hospitalizations 226 1,213
Average Patient Age 66.6 yrs 53.9 yrs
% Female Patients 37.9% 79.8%
FDA Approval Date Apr 12, 2019 Approved Prior to Jan 1, 1982
Manufacturer Janssen Products LP Bryant Ranch Prepack
Route ORAL TOPICAL
Marketing Status Prescription Discontinued